Navigation Links
AGA supports new guidelines favoring tests that prevent colorectal cancer
Date:3/5/2008

Bethesda, MD (March 5, 2008) New consensus colorectal cancer guidelines released today state for the first time that the primary goal of colorectal cancer screening is cancer prevention. Previous guidelines have given equal weight to tests for detecting cancer and preventing cancer. By removing polyps from the large bowel, colonoscopy is the only screening test that also prevents colorectal cancer.

Colorectal cancer prevention should be the primary goal of screening, said Nicholas LaRusso, MD, AGAF, president, American Gastroenterological Association (AGA) Institute. Detection and removal of precancerous lesions is essential to improve the health of Americans.

The guidelines, which represent the most current scientific evidence and expert opinion available, are a joint effort of the American Cancer Society, the American College of Radiology and the U.S. Multi-society Task Force (comprised of the American College of Gastroenterology, the American Gastroenterological Association (AGA) Institute and the American Society for Gastrointestinal Endoscopy).

While the AGA Institute considers optical colonoscopy the definitive screening and treatment procedure for colorectal cancer, we support all clinically proven options for colorectal cancer screening. There are many tests available for screening and everyone age 50+ should talk with their physician about what test is available to them, said John I. Allen, MD, MBA, AGAF chair of the AGA Institute Clinical Practice and Quality Management Committee.

The panel of experts representing the societies listed above added two new tests as options: stool DNA (sDNA) and CT colonography (CTC). The AGA Institute supports CTC as a promising screening test for colorectal cancer, which we believe will be in widespread clinical use in the near future.

The expert panel also concluded that any proposed colorectal screening test that has not been shown in the medical literature to detect the majority of cancers present at the time of testing should not be offered to patients for colorectal cancer screening, including some types of previously endorsed guiaic-based stool tests.

Based on a review of the historic and recent evidence, the following tests were deemed acceptable options for the early detection of colorectal cancer and adenomatous polyps for asymptomatic adults aged 50 years and older:

Tests That Detect Adenomatous Polyps and Cancer

  • Flexible sigmoidoscopy every 5 years, or
  • Colonoscopy every 10 years, or
  • Double contrast barium enema (DCBE) every 5 years, or
  • CT colonography (CTC) every 5 years

Tests That Primarily Detect Cancer

  • Annual guaiac-based fecal occult blood test (gFOBT) with high test sensitivity for cancer, or
  • Annual fecal immunochemical test (FIT) with high test sensitivity for cancer, or
  • Stool DNA test (sDNA), with high sensitivity for cancer, interval uncertain.

The guidelines will appear in the May issue Gastroenterology, May/June issue of CA: A Cancer Journal for Clinicians, and are published early online on CA First Look.


'/>"/>

Contact: Aimee Frank
media@gastro.org
301-941-2620
American Gastroenterological Association
Source:Eurekalert

Related medicine news :

1. Leading Natural Cosmetics Company Supports Breast Cancer Survivors
2. Encision Supports National Patient Safety Awareness Week
3. Highmark Inc. Supports Employee Volunteerism Efforts with $5,500 in Community Grants
4. AdvaMed Supports Key Changes to Disclosure Legislation
5. Michael Aram Supports The NAZ Foundation
6. Cogon Systems, Inc. Supports the Formation of Virtual Health Communities with its Community MOMENT OF CARE(R)
7. Evolutionary history of SARS supports bats as virus source
8. Seven Out of 10 Americans Would Vote for a Presidential Candidate Who Supports a Nationwide Health Information Network, CSC Survey Says
9. AT&T Tennessee Supports Local Disaster Relief Efforts
10. AIDS Action Committee Offers and Supports Variety of Events to Honor National Black HIV/AIDS Awareness Day
11. Cord Blood America Supports Trend From New York, California for States to Inform Parents of the Advantages of Umbilical Cord Blood Storage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... Amir Qureshi, MD is ... powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita SCS System has been ... pleased to be the first in Arkansas to introduce the most powerful SCS system ...
(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the Congressional Budget Office (CBO) ... House on May 4, would result in 23 million Americans losing their health insurance ... 2010 Patient Protection and Affordable Care Act (ACA). , “It is clear from ...
(Date:5/26/2017)... ... 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral surgeon specializing in ... post on insurance options. If a Bay Area patient has to search for a ... money. Visiting an in-network provider for a second opinion can ensure a patient receives ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “Cactus Jack: ... had on so many others. “Cactus Jack: Against All Odds” is the creation ... Walter D. Hubbard is married to Jack Carlisle’s third child Jane. Walter. ...
(Date:5/24/2017)... ... May 24, 2017 , ... Altec Products, ... in nVerge 2017 – a one-day technology conference in San Diego, CA. , ... which allows users to fully utilize and enhance their Sage ERP solutions by providing ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... Global Health Intelligence (GHI), the leading healthcare data ... its 2017 ranking of the Best-Equipped Hospitals in Latin ... from GHI,s hospitals database for Latin America , which ... GHI database covers 86% of the hospitals in ... for each institution in key areas such as beds, medical ...
(Date:5/10/2017)... 2017 CSSi, the global leader in patient ... industry, is proud to announce the launch of its ... features both enriched content and a customized layout that ... company,s already well-established position as the top global patient ... many months of hard work, we are delighted to ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
Breaking Medicine Technology: